Is Soy Safe For Breast Cancer Patients?

An article in a national newspaper recently sent out alarm signals about the use of soy products for women, in particular for those who have been diagnosed with breast cancer.

Soy is beneficial for many women, and used with caution and in moderation, but for women who are having treatment for breast cancer there is a definite problem.

Tamoxifen and soy

New advice is that women should not start eating soya products if they are on drugs such as Tamoxifen.

This is because the active ingredient in soy is genistein and this limits the effectiveness of some breast cancer treatments.

However this does not apply to women who have previously included soy as part of their regular diet. It is starting it at the same time as treatment that can be a problem.

Oestrogen and cancer

High doses of oestrogen have been linked to certain cancers, and ironically Tamoxifen is itself a weak oestrogen.

Soy is a phytoestrogen and its active compound, genistein, interferes with the actions of drugs used to treat breast cancer, including Tamoxifen.

Professor Leena Hilakivi-Clarke, of Georgetown Lombardi Comprehensive Cancer Centre, who conducted the research explained that timing of genistein intake is crucial.

‘Oestrogen drives most breast cancer growth, yet high soya intake among women in Asian countries has been linked to a breast cancer rate that is five times lower than Western women, who eat much less soya,’ she said.

So if your normal diet is already high in soya then there is no problem, but if you decide to switch your diet then experts warn that women shouldn’t start consuming soya milk or soy products after a breast cancer diagnosis – because it may limit the effectiveness of treatment.

The Nuance in Soy Research

The debate around soy and breast cancer is more complex than many headlines suggest. Population studies consistently show that women in Asian countries who consume soy regularly from a young age have significantly lower rates of breast cancer. However, the picture changes when Western women begin consuming large amounts of soy later in life, particularly after a cancer diagnosis.

The key factor appears to be timing and quantity. Lifelong, moderate consumption of whole soy foods — such as tofu, edamame, and traditional fermented soy products like miso and tempeh — seems to be protective. The concern arises specifically when concentrated soy supplements or large quantities of processed soy products are introduced during or alongside cancer treatment.

When Soy May Be Safe and When to Be Cautious

Based on current research, here are some general guidelines:

• If soy has always been part of your diet: there is generally no need to stop — moderate consumption of whole soy foods appears to be safe
• If you are on Tamoxifen or other breast cancer drugs: do not introduce new soy products or supplements — the genistein may interfere with treatment
• Concentrated soy supplements: these deliver much higher doses of isoflavones than whole foods and should be avoided by women with a breast cancer history
• Processed soy products: highly processed soy foods may not offer the same benefits as traditional whole soy foods

Alternatives to Soy for Phytoestrogens

If you want the benefits of phytoestrogens without relying on soy, there are plenty of alternatives. Flaxseed (linseed) is one of the richest sources of lignans, a type of phytoestrogen. Other good sources include sesame seeds, chickpeas, lentils, and the traditional “menopause cake” ingredients such as oats and sunflower seeds. These foods provide gentle oestrogenic support without the concerns associated with concentrated soy products.

As always, if you have been diagnosed with breast cancer or are undergoing treatment, discuss any dietary changes with your oncologist or healthcare provider.